Lyell Immunopharma, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold LYEL, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
15
Funds holding
$49439621
Total value held
Buying
12 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Gsk Plc | $30343940 | 1512659 | — | NEW BUY |
| 2 | Alphabet Inc. | $5882715 | 293256 | — | Held |
| 3 | Blackrock, Inc. | $3847910 | 191820 | +9983 | +5.49% |
| 4 | Invesco Ltd. | $3036416 | 98649 | — | NEW BUY |
| 5 | Goldman Sachs Group Inc | $2296689 | 114491 | +17816 | +18.43% |
| 6 | State Street Corp | $1454791 | 72522 | +21050 | +40.90% |
| 7 | Morgan Stanley | $1126389 | 56151 | +13202 | +30.74% |
| 8 | Bank Of America Corp /De/ | $668420 | 33321 | +25276 | +314.18% |
| 9 | Northern Trust Corp | $607417 | 30280 | — | Held |
| 10 | Citigroup Inc | $130292 | 4233 | +3203 | +310.97% |
| 11 | Barclays Plc | $33520 | 1671 | — | NEW BUY |
| 12 | Royal Bank Of Canada | $6000 | 251 | — | NEW BUY |
| 13 | Wells Fargo & Company/Mn | $3848 | 125 | — | NEW BUY |
| 14 | Us Bancorp \De\ | $1163 | 58 | — | Held |
| 15 | Amalgamated Financial Corp. | $111 | 21960 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.